Life Sciences Ontario
Life Sciences Ontario (LSO) strives to be the unified Voice of Life Sciences in Ontario by representing the interests of the diverse life sciences community in the province through advocacy, education, facilitation of economic development and promotion of the industry locally, nationally and internationally. Together we are a strong, innovative sector with significant socioeconomic contributions to the province of Ontario. We hope you will consider joining LSO and help us to achieve our vision for Ontario's life sciences sector - "Diversity of Members, Unity of Voice".
LSO Launches 2015 Sector Report
Wednesday, February 25, 2015
Life Sciences Ontario's 2015 Sector Report provides first evidence-based economic impact data and benchmarks against North American jurisdictions
If you work in the life sciences in Ontario, your wages are approximately 26.5 per cent higher than those of the provincial average. On the other hand, if you're a recent science graduate, you're facing a challenging unemployment rate of 18.9 per cent.
Dean On Campus Blog: Building bridges to industry with Paul Lucas
Friday, February 27, 2015
When I became Dean of the Faculty of Health Sciences at Queens and began talking about the idea of building partnerships with industry, I realized that I was entering into a divided world. The pendulum, with respect to industry-academic relationships had swung far to the left; communications were not open, relationships were fractured. I knew that bringing that pendulum back to the centre had to be a goal of mine, and yet I knew I couldnt do it alone.
Merck Announces a Contribution of $7.5 Million to the Structural Genomics Consortium (SGC) Toronto
Wednesday, February 4, 2015
TORONTO, February 4, 2015 /CNW/ - At an announcement made earlier today at MaRS Discovery District, Merck, known as MSD outside the United States and Canada, confirmed its commitment to research and innovation by contributing a total of $7.5 million to the Structural Genomics Consortium (SGC) Toronto and its network, thereby becoming a member of the consortium.
The supported projects focus on pre-competitive research to develop small inhibitory molecules called chemical probes to study epigenetic mechanisms of regulation. In collaboration with leading clinical institutions in Ontario and around the world, use of the probes will expand the understanding of biology in multiple disease areas, particularly cancer and inflammatory diseases.
Ontario Funding to Support Cancer Screening, Diagnosis and Treatment
Wednesday, February 4, 2015
Ontario is supporting world-class cancer research that will increase screening rates and help improve the lives of cancer patients across the province. The province's investment is helping the Ontario Institute for Cancer Research (OICR) carry out new research that will focus on:
Increasing screening rates for colon cancer.